Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Cipla promoters,...

    Cipla promoters, relatives get into share transfer agreement

    Written by Ruby Khatun Khatun Published On 2017-09-08T13:21:46+05:30  |  Updated On 8 Sept 2017 1:21 PM IST
    Cipla promoters, relatives get into share transfer agreement

    New Delhi: Drug firm Cipla said some of its promoters and promoter group along with their relatives have entered into an agreement on the transfer of their shares in the company.


    Under the shareholders' agreement, if any of the parties to the pact wishes to transfer their shares in the company, they shall first offer the other parties a pre-emptive right to acquire such shares, Cipla said in a filing to the BSE.


    The parties to the shareholders' agreement include promoters Y K Hamied and M K Hamied, who have 20.72 per cent and 3.93 per cent stake in Cipla, it added.


    The members of the promoter group include Samina Vaziralli, Shirin Hamied, Rumana Hamied, Kamil Hamied and Sophie Ahmed, among others, Cipla said.


    The relatives of the promoter group include Farah Barua, Sara Ahmed and Monisha Ahmed, daughters of Sophie Ahmed, it added.


    The total stake owned by promoters, the promoter group and their relatives constitutes around 37.52 per cent stake in Cipla.

    acquireagreementCiplaFarah BaruaKamil HamiedM K HamiedMonisha Ahmedpromoter groupPromotersrelativesRumana HamiedSamina VaziralliSara Ahmedshare transfer agreementshareholdersSharesShirin HamiedSophie AhmedY K Hamied
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok